NERV Q1 2023 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$58M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$5M

Net Income

-$7M

EPS (Diluted)

$-1.31

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$115,407

Free Cash Flow

-$115,407

Stock-Based Comp.

$376,459

Balance Sheet

Total Assets

$52M

Total Liabilities

$78M

Stockholders' Equity

-$27M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$5M	-$8M	+33.1%
Net Income	-$7M	-$10M	+28.6%